BNP Paribas Financial Markets’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $263K | Buy |
12,326
+7,525
| +157% | +$141K | ﹤0.01% | 4107 |
|
|
2026
Q1 | $83.9K | Buy |
4,801
+2,052
| +75% | +$40.7K | ﹤0.01% | 4460 |
|
|
2025
Q4 | $54K | Sell |
2,749
-100
| -4% | -$2.08K | ﹤0.01% | 4650 |
|
|
2025
Q3 | $78.5K | Sell |
2,849
-6,394
| -69% | -$197K | ﹤0.01% | 4407 |
|
|
2025
Q2 | $282K | Buy |
9,243
+8,379
| +970% | +$238K | ﹤0.01% | 3640 |
|
|
2025
Q1 | $23.3K | Sell |
864
-18,552
| -96% | -$587K | ﹤0.01% | 4496 |
|
|
2024
Q4 | $697K | Sell |
19,416
-3,279
| -14% | -$123K | ﹤0.01% | 3068 |
|
|
2024
Q3 | $861K | Sell |
22,695
-5,544
| -20% | -$228K | ﹤0.01% | 2583 |
|
|
2024
Q2 | $1.28M | Sell |
28,239
-10,581
| -27% | -$487K | ﹤0.01% | 2149 |
|
|
2024
Q1 | $1.88M | Buy |
38,820
+5,952
| +18% | +$291K | ﹤0.01% | 2088 |
|
|
2023
Q4 | $1.76M | Sell |
32,868
-5,522
| -14% | -$279K | ﹤0.01% | 2045 |
|
|
2023
Q3 | $2.25M | Buy |
38,390
+10,822
| +39% | +$677K | ﹤0.01% | 1806 |
|
|
2023
Q2 | $1.74M | Sell |
27,568
-2,215
| -7% | -$141K | ﹤0.01% | 1838 |
|
|
2023
Q1 | $1.87M | Buy |
29,783
+7,279
| +32% | +$434K | ﹤0.01% | 1866 |
|
|
2022
Q4 | $1.2M | Sell |
22,504
-7,047
| -24% | -$382K | ﹤0.01% | 2062 |
|
|
2022
Q3 | $1.66M | Buy |
29,551
+8,270
| +39% | +$547K | ﹤0.01% | 2097 |
|
|
2022
Q2 | $1.54M | Sell |
21,281
-3,119
| -13% | -$232K | ﹤0.01% | 1918 |
|
|
2022
Q1 | $1.94M | Buy |
24,400
+549
| +2% | +$49.5K | ﹤0.01% | 1842 |
|
|
2021
Q4 | $2.41M | Sell |
23,851
-4,887
| -17% | -$487K | ﹤0.01% | 1863 |
|
|
2021
Q3 | $2.65M | Buy |
28,738
+13,206
| +85% | +$1.27M | ﹤0.01% | 1702 |
|
|
2021
Q2 | $1.59M | Buy |
15,532
+10,341
| +199% | +$1.04M | ﹤0.01% | 1881 |
|
|
2021
Q1 | $507K | Buy |
5,191
+1,058
| +26% | +$96.3K | ﹤0.01% | 2559 |
|
|
2020
Q4 | $319K | Sell |
4,133
-29
| -0.7% | -$2.24K | ﹤0.01% | 2680 |
|
|
2020
Q3 | $307K | Buy |
4,162
+2,163
| +108% | +$174K | ﹤0.01% | 2498 |
|
|
2020
Q2 | $147K | Sell |
1,999
-13,536
| -87% | -$1.06M | ﹤0.01% | 2616 |
|
|
2020
Q1 | $897K | Buy |
15,535
+11,716
| +307% | +$815K | ﹤0.01% | 1988 |
|
|
2019
Q4 | $300K | Buy |
3,819
+1,522
| +66% | +$112K | ﹤0.01% | 2767 |
|
|
2019
Q3 | $157K | Sell |
2,297
-88
| -4% | -$5.91K | ﹤0.01% | 2876 |
|
|
2019
Q2 | $189K | Sell |
2,385
-819
| -26% | -$65K | ﹤0.01% | 2659 |
|
|
2019
Q1 | $269K | Buy |
3,204
+2,189
| +216% | +$228K | ﹤0.01% | 2508 |
|
|
2018
Q4 | $119K | Buy |
1,015
+283
| +39% | +$32.7K | ﹤0.01% | 2255 |
|
|
2018
Q3 | $88.2K | Sell |
732
-388
| -35% | -$48.2K | ﹤0.01% | 2805 |
|
|
2018
Q2 | $129K | Sell |
1,120
-1,497
| -57% | -$164K | ﹤0.01% | 2658 |
|
|
2018
Q1 | $225K | Sell |
2,617
-30,806
| -92% | -$2.39M | ﹤0.01% | 2725 |
|
|
2017
Q4 | $2.47M | Buy |
33,423
+31,669
| +1,806% | +$2.12M | ﹤0.01% | 1372 |
|
|
2017
Q3 | $101K | Sell |
1,754
-357
| -17% | -$21.1K | ﹤0.01% | 2779 |
|
|
2017
Q2 | $135K | Buy |
2,111
+245
| +13% | +$15.1K | ﹤0.01% | 2662 |
|
|
2017
Q1 | $107K | Sell |
1,866
-517
| -22% | -$30.9K | ﹤0.01% | 2466 |
|
|
2016
Q4 | $146K | Buy |
2,383
+1,025
| +75% | +$66.8K | ﹤0.01% | 2360 |
|
|
2016
Q3 | $93.9K | Buy |
1,358
+420
| +45% | +$27.7K | ﹤0.01% | 2133 |
|
|
2016
Q2 | $52.3K | Buy |
938
+670
| +250% | +$40.4K | ﹤0.01% | 2291 |
|
|
2016
Q1 | $16.3K | Sell |
268
-1,384
| -84% | -$81.5K | ﹤0.01% | 2175 |
|
|
2015
Q4 | $106K | Sell |
1,652
-1,536
| -48% | -$99.6K | ﹤0.01% | 1871 |
|
|
2015
Q3 | $214K | Buy |
3,188
+1,546
| +94% | +$109K | ﹤0.01% | 1910 |
|
|
2015
Q2 | $112K | Buy |
1,642
+1,360
| +482% | +$86.3K | ﹤0.01% | 2029 |
|
|
2015
Q1 | $15.7K | Sell |
282
-8,760
| -97% | -$449K | ﹤0.01% | 2494 |
|
|
2014
Q4 | $464K | Sell |
9,042
-1,574
| -15% | -$77.3K | ﹤0.01% | 1154 |
|
|
2014
Q3 | $391K | Buy |
10,616
+1,400
| +15% | +$50.5K | ﹤0.01% | 1616 |
|
|
2014
Q2 | $360K | Buy |
9,216
+356
| +4% | +$13.2K | ﹤0.01% | 1616 |
|
|
2014
Q1 | $301K | Buy |
+8,860
| New | +$309K | ﹤0.01% | 1659 |
|
Other funds holding USNA
NCM
BNP Paribas Financial Markets's USNA Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Usana Health Sciences (USNA) stake by 157% in Q2 2026, buying an estimated $141K and bringing the position to 12,326 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #4107.
BNP Paribas Financial Markets first reported a position in USNA in Q1 2014 and has held it in 50 quarters since. The position peaked at $2.65M in Q3 2021. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.
- BNP Paribas Financial Markets held 12,326 shares of Usana Health Sciences worth $263K as of Q2 2026.
- BNP Paribas Financial Markets bought 7,525 Usana Health Sciences shares in Q2 2026, an estimated $141K.
- Usana Health Sciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4107 holding.
- BNP Paribas Financial Markets first reported a position in Usana Health Sciences in Q1 2014 and has held it in 50 quarters since.
- BNP Paribas Financial Markets's Usana Health Sciences position peaked at $2.65M in Q3 2021.
- 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.